drug development
Guardant Health, Cota Partner to Provide Clinicogenomic Cancer Data Resource for Biopharma
The companies believe that creating a unified set of clinical and genomic data will help biopharma clients accelerate their development of new targeted therapies.
Danaher Launches US, UK Laboratories for Precision Medicine Test Development
The CLIA- and CAP-certified laboratories are intended to accelerate the development of companion diagnostics and complementary diagnostics.
Adaptive Biotechnologies, BeiGene Partner for Lymphoid Malignancy Drug Development
Adaptive’s ClonoSeq assay will be used to assess MRD across BeiGene’s pipeline of treatments for patients with lymphoid malignancies.
Foundation Medicine, Bristol Myers Squibb Expand CDx Partnership to Investigational Cancer Drug
The companies are working to establish FoundationOne CDx as a companion diagnostic for BMS's investigational tyrosine kinase inhibitor repotrectinib.
Guardant Health Licenses Genomic Cancer Assays to Adicon for Testing in China
Under the agreement, Adicon will provide biopharmaceutical companies conducting clinical trials in China access to Guardant's tissue and liquid biopsy tests.